Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms [Yahoo! Finance]
Aditxt, Inc. (ADTX)
Company Research
Source: Yahoo! Finance
-- PHEXXI ® is #1 most followed contraceptive brand on social media by healthcare providers -- SAN DIEGO Sept. 11, 2025 /PRNewswire/ -- Evofem Biosciences, Inc. (Evofem) (OTCID: EVFM) today announced the conclusion and exciting impact of its groundbreaking August 2025 "Say Vagina" campaign, which aimed to normalize the use of clinical anatomical language and to combat the widespread censorship of essential medical terminology. Women's health innovator Evofem Biosciences (OTCQB: EVFM) (PRNewsfoto/Evofem Biosciences, Inc.) This edgy and provocative campaign tapped into areas of urgent educational need and partnered with leaders across multiple fields. Tangible Campaign Impact More than 2.5 million views were generated across social media platforms. 130% increase in traffic to phexxi.com , the website for Evofem's hormone-free prescription. contraceptive PHEXXI ® (lactic acid citric acid and potassium bitartrate), during Say Vagina Month. PHEXXI ® is now the most followed
Show less
Read more
Impact Snapshot
Event Time:
ADTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADTX alerts
High impacting Aditxt, Inc. news events
Weekly update
A roundup of the hottest topics
ADTX
News
- Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta’s Planned IPO, And Evofem’s Plan to Regain a National ListingBusiness Wire
- Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025Business Wire
- Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global MarketBusiness Wire
- Evofem Announces Voting Results from Special Meeting of StockholdersPR Newswire
- Aditxt (NASDAQ:ADTX) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
ADTX
Sec Filings
- 12/5/25 - Form PRER14A
- 12/5/25 - Form 8-K
- 11/26/25 - Form 4
- ADTX's page on the SEC website